US manufacturer JM Smucker has reportedly taken aim at one of the country’s foremost retailers with a lawsuit centred on the Uncrustables brand. According to media reports in the US, JM Smucker has filed a suit in Ohio accusing Trader Joe’s of selling sandwiches that mimic its Uncrustables products. In a document posted online by Reuters detailing the lawsuit, the manufacturer claimed Trader Joe’s “has launched an obvious copycat” with its own Crustless Peanut Butter & Strawberry Jam sandwiches. “Smucke ...

I’m an equity analyst and founder of Goulart’s Restaurant Stocks, a research firm focused on the U.S. restaurant industry — from quick-service and fast casual to fine dining and niche concepts. I lead all thematic research and valuation efforts, applying advanced financial modeling, sector-specific KPIs, and strategic insights to uncover hidden value across public equities. In addition to restaurants, I cover consumer discretionary, food & beverage, casinos & gaming, and IPOs, with a particular focus on mic ...

I’m an equity analyst and founder of Goulart’s Restaurant Stocks, a research firm focused on the U.S. restaurant industry — from quick-service and fast casual to fine dining and niche concepts. I lead all thematic research and valuation efforts, applying advanced financial modeling, sector-specific KPIs, and strategic insights to uncover hidden value across public equities. In addition to restaurants, I cover consumer discretionary, food & beverage, casinos & gaming, and IPOs, with a particular focus on mic ...

Core Insights - Apple has introduced several product updates, including a refreshed MacBook Pro, an iPad Pro, and a second generation of the Vision Pro headset, integrating its latest M5 chip across these devices [1] Product Updates - The refreshed MacBook Pro features the latest M5 chip, enhancing performance and efficiency [1] - The new iPad Pro also incorporates the M5 chip, indicating a focus on improving processing power and user experience [1] - The second generation of the Vision Pro headset showcases advancements in technology, likely aimed at enhancing virtual and augmented reality experiences [1]

With the news that Verizon Communications Inc. (NYSE: VZ ) has made a somewhat sudden change in management , ousting CEO Hans Vestberg in favor of incoming Dan Schulman, I wanted to return to the tickerMax Greve is a graduate of Northwestern University with a quadruple major in History, Economics, Political Science, and International Studies. Max is a full-time writer and in addition to stock market trends also writes articles on government, current events, macroeconomic trends, and last but not least, the ...

CVS has finished buying customer prescription files from hundreds of closed Rite Aid drugstores and is now running 63 of the defunct chain’s locations. The company said Wednesday that it is operating former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. It also has transferred customer prescription files from 626 pharmacies in 15 states to nearby CVS locations. CVS Health did not say how much it spent on the stores and prescription files. Rite Aid recently announced on its website th ...

While reaching retirement age can be both a blessing and a curse, relying on the U.S. ...

Key Takeaways NVIDIA's networking revenues jumped 98% year over year to $7.25 billion in Q2 fiscal 2026.The Spectrum-X platform delivers near-InfiniBand performance for AI workloads on Ethernet systems.The Spectrum-XGS launch aims to link multiple AI factories, expanding NVIDIA's networking dominance.NVIDIA Corporation’s (NVDA) networking business has become a critical part of its overall growth story, and the Spectrum-X platform could take it to the next level. In the second quarter of fiscal 2026, network ...

Key Takeaways A. O. Smith declared a $0.36 dividend per share, payable Nov. 17, with a 2.01% yield.Lockheed Martin announced a $3.45 dividend per share, payable Dec. 30, with a 2.62% yield.THOR Industries raised its dividend to $0.52 per share, payable Nov. 6, with a 1.98% yield.Volatility has returned to Wall Street, with all three major indexes retreating from their all-time highs. Concerns over high inflation, a shrinking labor market and renewed trade war fears with China have been denting investors’ se ...

Key Takeaways Pfizer agreed to buy Metsera for $4.9B, marking its return to the obesity space.Roche plans a $3.5B acquisition of 89bio to expand into metabolic liver disease.Novo Nordisk will purchase Akero Therapeutics for $4.7B to deepen its MASH pipeline.After a muted start to 2025, Big Pharma is back on the M&A trail. In just a month, three major players — Pfizer (PFE) , Novo Nordisk (NVO) and Roche (RHHBY) — announced multi-billion-dollar deals targeting the fast-growing, lucrative metabolic and obesit ...